Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Diagnostic Study of Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging for the Localization of Prostate Cancer Prior to Radical Prostatectomy

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Diagnostic	Completed	18 and over	NCI	ACRIN-6659 NCT00032058

Trial Description

Purpose:

Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate cancer. It is not yet known if MRI combined with MRSI is more effective than MRI alone in detecting the extent of prostate cancer.

Diagnostic trial to compare the effectiveness of combining MRI with MRSI to that of MRI alone in determining the extent of prostate cancer in patients who are scheduled to undergo surgery to remove the prostate gland.

Eligibility:

Eligibility criteria include the following:

• At least 18 years old
• At least 6 weeks since biopsy
• Surgery to remove the prostate gland scheduled within 6 months of MRI and MRSI
• No previous BCG for bladder cancer
• No previous hormone therapy
• No previous radiation therapy to the prostate gland or rectum
• No previous cryosurgery, prostate surgery, transurethral resection of the prostate (TURP), or rectal surgery
• No previous complementary and alternative medicine
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

At least 6 weeks after biopsy, patients will undergo MRI and MRSI. Within 6 months, patients will undergo surgery to remove the prostate gland.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

American College of Radiology Imaging Network

Jeffrey Weinreb, MD, Protocol chair		Ph: 203-785-5913 Email: jeffrey.weinreb@yale.edu

Registry Information
Official Title		MR Imaging And MR Spectroscopic Imaging Of Prostate Cancer Prior To Radical Prostatectomy: A Prospective Multi-Institutional Clinicopathological Study
Trial Start Date		2003-06-26
Trial Completion Date		2006-06-14
Registered in ClinicalTrials.gov		NCT00032058
Date Submitted to PDQ		2002-01-25
Information Last Verified		2005-04-26
NCI Grant/Contract Number		CA080098

Back to Top